Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens ...
Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens ...
Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...
Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Please provide your email address to receive an email when new articles are posted on . Part one of this series focused on balancing the three interrelated concepts of presbyopia-correcting or visual ...
poses a challenge. Key market players include Alcon Inc., Aurolab, Bausch Lomb Corp., BVI Holdings Ltd., Carl Zeiss AG, EyeKon Medical Inc., HOYA CORP., HumanOptics ...
The global intraocular lens market is experiencing significant growth, with 2022 sales projected to reach USD 4.6 billion, according to a newly released analysis from Future Market Insights. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback